IGF-1 vs IGF-1 LR3: The Two Are Not Interchangeable, and People Order the Wrong One Constantly
Native IGF-1 and the LR3 analogue are treated as the same product across most of the market. They are structurally different molecules with different binding-protein behaviour and different half-lives. If your protocol specifies one, the other will not do.
- Native IGF-1 is recombinant insulin-like growth factor 1 — the endogenous sequence. IGF-1 LR3 is a modified analogue, not the same molecule.
- LR3 carries an arginine substitution at position 3 and a 13-residue N-terminal extension, modifications that sharply reduce its affinity for IGF binding proteins.
- Reduced binding-protein affinity is the entire purpose of LR3: it substantially extends the analogue’s functional half-life relative to the native peptide.
- For research questions involving binding-protein interaction itself, the native sequence is the correct tool and the analogue is actively wrong.
- Popular Peptides supplies both, each at greater than 99% purity with a batch-specific third-party certificate of analysis.
- For in vitro laboratory research use only — not for human or veterinary consumption.
Two products, one name, constant confusion
Search for IGF-1 and you will be shown IGF-1 LR3. Many suppliers list them under one heading and let the customer sort it out. They are not the same molecule, and if your protocol specifies one, the other will not substitute.
We list them separately on purpose: native IGF-1 and IGF-1 LR3.
What actually differs
**Native IGF-1** is recombinant insulin-like growth factor 1 — the endogenous 70-amino-acid sequence, produced recombinantly. What you get is the molecule the body actually makes.
**IGF-1 LR3** is an engineered analogue with two modifications:
1. An **arginine substitution at position 3** (hence "R3").
2. A **13-amino-acid N-terminal extension** (hence "Long").
Neither change is cosmetic. Together they dramatically reduce the molecule's affinity for **IGF binding proteins** — the circulating carrier proteins that bind the great majority of native IGF-1 and regulate how much is free at any moment.
Why that single property decides which one you need
Binding-protein affinity is not a footnote. It is the whole design rationale.
Native IGF-1 is extensively bound by IGFBPs, which regulate its availability and give it a short functional window. LR3, engineered to evade those proteins, remains free far longer — a substantially extended functional half-life compared to the native peptide.
So the choice follows directly from the question being asked:
- —**Studying IGF binding protein interaction, regulation, or the native signalling axis as it actually operates?** Use native IGF-1. The analogue was specifically built to bypass the mechanism you are trying to observe.
- —**Need sustained receptor-level exposure without binding-protein modulation as a variable?** LR3 exists for that reason.
Picking the wrong one does not produce a slightly different result. It produces an answer to a different question. This is the single most common ordering error in this corner of the catalogue, and it usually surfaces only after the experiment has run.
Our reference library carries molecular data for both, and the comparison pages place them side by side.
Buying a recombinant protein without getting burned
IGF-1 is a recombinant protein, not a solid-phase-synthesised peptide, and that changes what can go wrong. Proteins misfold. They denature in transit. A vial can contain the correct sequence and still be functionally useless if it was handled badly on the way to you.
Which makes two things non-negotiable:
- —**Independent third-party testing per batch** — HPLC for purity, LC-MS for identity, run by a lab that is not us. Published-batch purity averages above 99%. Look up your lot number and read the certificate for your exact vial, or review all published results first.
- —**A short, controlled, domestic shipping route.** This matters more for a recombinant protein than for anything else in the catalogue. Ours ships from **Vancouver, BC**, typically 2 to 5 business days, tracked and insured. It does not sit in a customs queue of unknown duration at an unknown temperature, because it does not cross a border. Compounds bought from offshore suppliers do, on every order — and cold-chain integrity is exactly the thing that queue destroys. A denatured protein looks identical to an intact one.
Canadian dollars, card or Interac e-Transfer, free shipping over $300 CAD, discreet insured packaging, and support that answers in your time zone.
Frequently asked questions
What is the difference between IGF-1 and IGF-1 LR3?
Native IGF-1 is the endogenous recombinant sequence. IGF-1 LR3 is a modified analogue carrying an arginine substitution at position 3 and a 13-residue N-terminal extension, which sharply reduce its affinity for IGF binding proteins and substantially extend its functional half-life.
Which one should I use for my research?
If the research question involves IGF binding protein interaction or the native signalling axis as it normally operates, use native IGF-1 — LR3 was designed specifically to bypass that mechanism. If sustained receptor exposure without binding-protein modulation is what you need, LR3 exists for that purpose.
Is IGF-1 LR3 stronger than IGF-1?
Not stronger in the sense of receptor potency. It is longer-acting, because evading IGF binding proteins keeps more of it free for longer. That is a difference in duration and availability, not raw activity.
What purity is your IGF-1?
Greater than 99%, verified by HPLC for purity and LC-MS for identity by an independent third-party laboratory, with a certificate of analysis retrievable by lot number on our verification page.
Where can I buy IGF-1 in Canada?
Popular Peptides supplies both native IGF-1 and IGF-1 LR3 for laboratory research use, shipped domestically from Vancouver, BC — a short, controlled route that matters particularly for recombinant proteins. Each carries a third-party certificate of analysis verifiable by lot number.
IGF-1 is supplied for in vitro laboratory research use only. It is not approved by Health Canada for therapeutic use and is not intended for human or veterinary consumption. 18+.
Every batch we sell is independently third-party tested, with the full Certificate of Analysis published and checkable by lot number.